Insights

Lab technician conducting a MSAC funded diagnostic test

5 Common Mistakes Sponsors Make in MSAC Submissions for Diagnostic and Investigative Technologies

5 months ago

For sponsors seeking public reimbursement in Australia, submissions for diagnostic and investigative technologies present a fundamentally different challenge to therapeutic services. Under the Medical Services Advisory Committee (MSAC) framework, diagnostic…

Top 8 things medical device companies need to know after the Prescribed List reforms

Insights

6 months ago

For medical device companies seeking reimbursement in the Australian private hospital system, inclusion on the Prescribed List (PL) remains critical. What has changed is that the Prescribed List is no…

The digital health market access challenge in Australia

Insights

1 year ago

What we’re seeing We’ve been working with some remarkable Australian digital health companies lately. These are teams with genuinely impressive clinical evidence and technology that could meaningfully improve patient care.…

Keeping pace with PBAC and MSAC key dates

Insights

1 year ago

Staying ahead in the pharma and medtech sectors requires a deep understanding of regulatory and advisory timelines, such as those set by the PBAC (Pharmaceutical Benefits Advisory Committee) and MSAC…

Positioning Australia’s life sciences industry for global success

Insights

1 year ago

Australia is a leader in niche life science segments with strong global markets, including plasma therapies, hearing implants, and sleep apnoea devices. Yet, despite billions in public and private investment,…

Reimbursement process for high cost, highly specialised therapies in public hospitals

Insights

2 years ago

In today’s rapidly evolving healthcare landscape, navigating the reimbursement pathway for high-cost highly specialised therapies presents a formidable challenge. These treatments, including groundbreaking innovations like cell and gene therapies, offer…

Finding Australian Real-World Data for Reimbursement Submissions: A Guide

Insights

2 years ago

Introduction Navigating the pathway to reimbursement can often feel like an uphill battle, and you’re not alone in this struggle. Market Access professionals frequently encounter challenges such as: Difficulty securing…

Environmental sustainability in Health Technology Assessment (HTA)

Insights

2 years ago

It’s a busy time for sustainability in healthcare: ISPOR Australia Chapter: Incorporating Sustainability in HTA conference (23 July 2024) Australian Healthcare and Hospitals Association: Sustainability Accelerator Tool (SAT) webinar (25…

Unlocking Consumer Insights in Health Technology Assessment

Insights

2 years ago

Ever asked for feedback? The results can often be quite surprising. We might find ourselves pondering questions like, “Why did they focus on that particular point?” or “Why did they…

Harnessing Real World Data and Evidence

Insights

2 years ago

What’s the Difference Between Real World Data and Real World Evidence? While often used interchangeably, there is clear distinction between the terms Real World Data (RWD) and Real World Evidence…